Guidelines updated for contrast agent use in clinical echoes

Guidelines updated for contrast agent use in clinical echoes

(HealthDay)—Initiatives have been developed to improve the appropriate use of contrast media in echocardiography. The guidelines were published in the August issue of the Journal of the American Society of Echocardiography.

Thomas R. Porter, M.D., from the University of Nebraska Medical Center in Omaha, and colleagues developed an updated guide for sonographers related to the use of contrast media in .

The researchers recommend encouraging programs and initiatives that will help sonographers to improve use of contrast in critical care settings, where the of contrast are increasingly being recognized. Prospective studies should be conducted to assess the value of contrast in these settings. The authors note that contrast media is currently not being used uniformly, and use is inappropriately low. Initiatives to improve appropriate use include: (1) working with various organizations to increase awareness of the value of contrast media in different settings; (2) rebranding to "ultrasound enhancing agent;" (3) increasing the number of trained sonographers; and (4) recommending that industry implement very low mechanical index software for all two- and three-dimensional platforms, which should be branded "optimal enhancement" software.

"This document is designed to help sonographers overcome the technical and administrative barriers to contrast utilization," the authors write. "With further technological modifications and the adoption of ultrasound enhancement agents into clinical echocardiographic practice, we anticipate additional updates to these guidelines in the future."

Several authors disclosed financial ties to the pharmaceutical and medical device industries.

More information: Full Text

add to favorites email to friend print save as pdf

Related Stories

ACG: New guidelines issued for irritable bowel syndrome

Aug 08, 2014

(HealthDay)—New guidelines have been issued in relation to the management of irritable bowel syndrome (IBS) and chronic idiopathic constipation. The updated guidelines were published as a supplement to ...

Recommended for you

German Merck to buy St. Louis-based Sigma-Aldrich

Sep 22, 2014

German drug company Merck says it has agreed to buy St. Louis-based chemical firm Sigma-Aldrich Corp. for $17 billion in a deal Merck says will strengthen its business in chemicals and laboratory equipment.

The human race evolved to be fair for selfish reasons

Sep 19, 2014

"Make sure you play fairly," often say parents to their kids. In fact, children do not need encouragement to be fair, it is a unique feature of human social life, which emerges in childhood. When given the o ...

User comments